Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kura Oncology (KURA)

Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kura Oncology 12730 HIGH BLUFF DRIVE SUITE 400 SAN DIEGO CA 92130 USA

www.kuraoncology.com Employees: 142 P: 858-500-8800

Description:

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Key Statistics

Overview:

Market Capitalization, $K 1,237,225
Enterprise Value, $K 1,209,235
Shares Outstanding, K 77,764
Annual Sales, $ 0 K
Annual Net Income, $ -152,630 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -54,400 K
EBIT, $ -217,490 K
EBITDA, $ -226,060 K
60-Month Beta 0.86
% of Insider Shareholders 5.50%
Float, K 73,487
% Float 94.50%
Short Volume Ratio 0.36

Growth:

1-Year Return 24.73%
3-Year Return 13.60%
5-Year Return -0.19%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -20.93%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.63 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -2.36
EPS Growth vs. Prev Qtr -6.78%
EPS Growth vs. Prev Year -26.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.09%
Return-on-Assets % -39.57%
Profit Margin % 0.00%
Debt/Equity 0.02
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.90
Book Value/Share 5.53
Interest Coverage -97.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar